REVERSE OF DOCETAXEL RESISTANCE IN PROSTATE CANCER VIA NOTCH SIGNALING INHIBITION

被引：0
|
作者：
Shi, Qiu
Tu, Xiang
Wei, Qiang
Yang, Lu
机构：
来源：
JOURNAL OF UROLOGY | 2018年 / 199卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP70-11
引用
收藏
页码：E938 / E938
页数：1
相关论文
共 50 条
  • [31] Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes
    Corcoran, Claire
    Rani, Sweta
    O'Brien, Keith
    O'Neill, Amanda
    Prencipe, Maria
    Sheikh, Rizwan
    Webb, Glenn
    McDermott, Ray
    Watson, William
    Crown, John
    O'Driscoll, Lorraine
    PLOS ONE, 2012, 7 (12):
  • [32] Antiandrogens inhibit ABCB1 Efflux and ATPase Activity and Reverse Docetaxel Resistance in Advanced Prostate Cancer
    Zhu, Yezi
    Liu, Chengfei
    Armstrong, Cameron
    Lou, Wei
    Sandher, Amandeep
    Gao, Allen C.
    CLINICAL CANCER RESEARCH, 2015, 21 (18) : 4133 - 4142
  • [33] Uc.63+promotes resistance to docetaxel through regulation of androgen receptor signaling in prostate cancer
    Sekino, Yohei
    Sakamoto, Naoya
    Goto, Keisuke
    Honma, Ririno
    Shigematsu, Yoshinori
    Sentani, Kazuhiro
    Oue, Naohide
    Teishima, Jun
    Matsubara, Akio
    Yasui, Wataru
    CANCER SCIENCE, 2018, 109 : 1071 - 1071
  • [34] Docetaxel resistance mechanisms in prostate cancer: p38 MAPK signaling pathway and microtubule dynamics
    Li, Weijuan
    Balakumaran, Bala
    Febbo, Phillip G.
    CANCER RESEARCH, 2011, 71
  • [35] Inhibition of Notch Signaling in Glioblastoma Targets Cancer Stem Cells via an Endothelial Cell Intermediate
    Hovinga, Koos E.
    Shimizu, Fumiko
    Wang, Rong
    Panagiotakos, Georgia
    Van Der Heijden, Maartje
    Moayedpardazi, Hamideh
    Correia, Ana Sofia
    Soulet, Denis
    Major, Tamara
    Menon, Jayanthi
    Tabar, Viviane
    STEM CELLS, 2010, 28 (06) : 1019 - 1029
  • [36] Solamargine Inhibits Prostate Cancer Cell Growth and Enhances the Therapeutic Efficacy of Docetaxel via Akt Signaling
    Ge, Jianchao
    Wang, Pengyu
    Ma, Hangbin
    Zhang, Jun
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [37] Notch Signaling Pathway and Endocrine Resistance in Breast Cancer
    Bai, Jing-Wen
    Wei, Min
    Li, Ji-Wei
    Zhang, Guo-Jun
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [38] Notch Pathway Inhibition Using PF-03084014, a γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer
    Cui, Di
    Dai, Jinlu
    Keller, Jill M.
    Mizokami, Atsushi
    Xia, Shujie
    Keller, Evan T.
    CLINICAL CANCER RESEARCH, 2015, 21 (20) : 4619 - 4629
  • [39] Notch Signaling in Breast Cancer: A Role in Drug Resistance
    BeLow, McKenna
    Osipo, Clodia
    CELLS, 2020, 9 (10)
  • [40] HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a -secretase inhibitor) partly reverses the resistance of refractory prostate cancer to docetaxel and enzalutamide in vitro
    Du, Zhongbo
    Li, Luo
    Sun, Wei
    Wang, Xiao
    Zhang, Yao
    Chen, Zhixiong
    Yuan, Mengjuan
    Quan, Men
    Liu, Nanjing
    Hao, Yanni
    Li, Ting
    Wang, Jinhua
    Luo, Chunli
    Wu, Xiaohou
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 53 (01) : 99 - 112
12345